Key Record Dates Identifier: NCT03394365
Brief Title: Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

First Submitted : December 29, 2017
First Submitted that Met QC Criteria : January 4, 2018
First Posted : January 9, 2018

Last Update Submitted that Met QC Criteria : March 24, 2021
Last Update Posted : March 26, 2021